The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Modified gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer (MPC): A single-institution experience.
 
Kavya Krishna
No Relationships to Disclose
 
Marlo A. Blazer
No Relationships to Disclose
 
Lai Wei
No Relationships to Disclose
 
Daniel H. Ahn
No Relationships to Disclose
 
Christina Sing-Ying Wu
No Relationships to Disclose
 
Kristen Keon Ciombor
No Relationships to Disclose
 
Sameh Mikhail
No Relationships to Disclose
 
Anne M. Noonan
No Relationships to Disclose
 
Richard M. Goldberg
Honoraria - Biothera; Lilly; Sanofi
Research Funding - Bayer (Inst); Immunomedics (Inst); Merck (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Merck KGaA; Sanofi
 
Tanios S. Bekaii-Saab
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Lilly; Regeneron
Research Funding - NCCN; NCI; Oncolytics
Expert Testimony - Helsinn Therapeutics
Other Relationship - Exelixis; Polaris